Skip to main content

Hyperion Capital Advisors LP

SEC CIK
0001794499
Latest filing
Aug 13, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Hyperion Capital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
42,924
Value
$16.6M
% of portfolio
7.5%
Quarters held
22
Since Q1 2021
Holdings of ELV by Hyperion Capital Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,924$16.6M7.5%−7,833−15.4%ReducedHolders
Q1 202650,757$14.9M7.2%−886−1.7%ReducedHolders
Q4 202551,643$18.1M8.9%00.0%UnchangedHolders
Q3 202551,643$16.7M8.9%+16,429+46.7%AddedHolders
Q2 202535,214$13.7M8.6%+9,000+34.3%AddedHolders
Q1 202526,214$11.4M6.2%−22,784−46.5%ReducedHolders
Q4 202448,998$18.1M9.3%+10,105+26.0%AddedHolders
Q3 202438,893$20.2M9.5%−512−1.3%ReducedHolders
Q2 202439,405$21.4M10.0%−104−0.3%ReducedHolders
Q1 202439,509$20.5M9.7%00.0%UnchangedHolders
Q4 202339,509$18.6M10.1%−2,000−4.8%ReducedHolders
Q3 202341,509$18.1M9.9%+14,611+54.3%AddedHolders
Q2 202326,898$12.0M6.5%+3,993+17.4%AddedHolders
Q1 202322,905$10.5M5.1%−330−1.4%ReducedHolders
Q4 202223,235$11.9M5.9%+1,147+5.2%AddedHolders
Q3 202222,088$10.0M4.9%+4,524+25.8%AddedHolders
Q2 202217,564$8.48M4.0%−8,228−31.9%ReducedHolders
Q1 202225,792$12.7M4.8%−2,762−9.7%ReducedHolders
Q4 202128,554$13.2M3.0%+1,861+7.0%AddedHolders
Q3 202126,693$9.95M2.6%+2,789+11.7%AddedHolders
Q2 202123,904$9.13M2.6%+9,942+71.2%AddedHolders
Q1 202113,962$5.01M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.